Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

March 9, 2021

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Advanced Solid Tumor Cancer
Interventions
DRUG

ABBV-CLS-484

Oral Capsule

DRUG

Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI)

Oral Tablet

DRUG

Programmed Cell Death-1 (PD-1) Inhibitor

Intravenous (IV) infusion

Trial Locations (30)

10016

RECRUITING

NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York

13009

RECRUITING

Institut Paoli-Calmettes /ID# 260956, Marseille

15232

RECRUITING

UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh

19104

RECRUITING

Perelman Center for Advanced Medicine /ID# 250188, Philadelphia

21287

RECRUITING

Johns Hopkins Hospital /ID# 254056, Baltimore

27710

RECRUITING

Duke Cancer Center /ID# 251975, Durham

28041

RECRUITING

Hospital Universitario 12 de Octubre /ID# 257374, Madrid

28050

RECRUITING

Hospital Universitario HM Sanchinarro /ID# 228034, Madrid

28078

COMPLETED

Carolina BioOncology Institute /ID# 225704, Huntersville

31059

RECRUITING

IUCT Oncopole /ID# 252673, Toulouse

48109

RECRUITING

University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor

77030

RECRUITING

University of Texas MD Anderson Cancer Center /ID# 252004, Houston

78229

COMPLETED

NEXT Oncology /ID# 225708, San Antonio

85724

RECRUITING

University of Arizona Cancer Center - Tucson /ID# 262698, Tucson

91120

RECRUITING

Hadassah Medical Center /ID# 252366, Jerusalem

92151

RECRUITING

Hopital Foch /ID# 252607, Suresnes

4941492

RECRUITING

Rabin Medical Center /ID# 263631, Petah Tikva

5265601

RECRUITING

The Chaim Sheba Medical Center /ID# 226756, Ramat Gan

06510

RECRUITING

Yale University School of Medicine /ID# 225707, New Haven

02215-5400

RECRUITING

Beth Israel Deaconess Medical Center /ID# 252009, Boston

02215

RECRUITING

Dana-Farber Cancer Institute /ID# 249642, Boston

02903-4923

RECRUITING

Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence

75390-7208

RECRUITING

University of Texas Southwestern Medical Center /ID# 251974, Dallas

06189

RECRUITING

Centre Antoine-Lacassagne /ID# 252606, Nice

104-0045

RECRUITING

National Cancer Center Hospital /ID# 225884, Chuo-ku

641-8510

RECRUITING

Wakayama Medical University Hospital /ID# 252988, Wakayama

03080

RECRUITING

Seoul National University Hospital /ID# 254635, Seoul

06351

RECRUITING

Samsung Medical Center /ID# 260664, Seoul

03722

RECRUITING

Yonsei University Health System Severance Hospital /ID# 260665, Seoul

08907

RECRUITING

Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 252524, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Calico Life Sciences LLC

INDUSTRY

lead

AbbVie

INDUSTRY